The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vasil'ev D.A.

FGU NII onkologii im. N.N. Petrova Minzdravsotsrazvitiia Rossii, Sankt-Peterburg

Basylev V.V.

Federal Center for Cardiovascular Surgery under Ministry of Health of the Russian Federation, 440071, Penza, Russia

Evtiushkin I.A.

FTsSSKh, Penza

Dynamics of pro-inflammatory cytokines and C-reactive protein after heart valve replacement in patients with non-complicated early postoperative period

Authors:

Vasil'ev D.A., Basylev V.V., Evtiushkin I.A.

More about the authors

Read: 2275 times


To cite this article:

Vasil'ev DA, Basylev VV, Evtiushkin IA. Dynamics of pro-inflammatory cytokines and C-reactive protein after heart valve replacement in patients with non-complicated early postoperative period. Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(3):59‑63. (In Russ.)

Recommended articles:
Opti­mal cardioplegia for coro­nary artery bypass grafting in patients with heart failure: a randomized study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):405-411
Gastrointestinal tract protection with nitric oxide in aortic arch surgery: a randomized study. Russian Journal of Anesthesiology and Reanimatology. 2025;(4):13-20
Inte­rleukin-6 as a biochemical marker of inte­stinal anastomotic leakage. Piro­gov Russian Journal of Surgery. 2025;(9):87-93

References:

  1. Bokeriya L.A., Gudkova R.G. Serdechno-sosudistaya khirurgiya - 2006. Bolezni i vrozhdennye anomalii sistemy krovoobrashcheniya. M: NTsSSKh 2007; 118.
  2. Belenkov Yu.N., Mareev V.Yu., Ageev F.T., Danielyan M.O. Ot imeni rabochei gruppy OSSN. Pervye rezul'taty natsional'nogo epidemiologicheskogo issledovaniya - epidemiologicheskoe obsledovanie bol'nykh KhSN v real'noi praktike (po obrashchaemosti) - EPOKhA-O-KhSN. Serdechnaya nedostatochnost' 2003; 4-3: 116-120.
  3. Kalyagin A.N. Osobennosti kuratsii bol'nykh s khronicheskoi revmaticheskoi bolezn'yu serdtsa v sovremennykh usloviyakh. Mezhdunarodnyi forum "Aktual'nye problemy sovremennoi nauki", 22-i: Trudy. Estestvennye nauki. Ch. 27. Meditsinskie nauki. Samara 2006; 302-333.
  4. Mareev V.Yu., Ageev F.T., Arutyunov G.P. i dr. Rossiiskie natsional'nye Rekomendatsii VNOK I OSSN po diagnostike i lecheniyu KhSN (vtoroi peresmotr). Serdechnaya nedostatochnost' 2007; 1: 1236.
  5. Erdes Sh.F., Folomeeva O.M. Revmaticheskie zabolevaniya i invalidnost' vzroslogo naseleniya Rossiiskoi Federatsii. Nauchno-prakt revmatol 2007; 4: 429.
  6. Aouifi A., Piriou V., Blanc P. et al. Effect of cardiopulmonary bypass on C-reactive protein concentration. Crit Care Med 2000; 28: 9: 3171-3176.
  7. Bachetti T., Comini L., Pasini E., Ferrari R. Anti-cytokine therapy in chronic heart failure: new approaches and unmet promises. Eur Heart J 2004; 6: 16-22.
  8. Jessup M., Brozena S. Heart failure. N Engl J Med 2003; 348: 2007-2018.
  9. Hirota H., Chen J., Betz U.A. et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999; 97: 189-198.
  10. Li Y.Y., Feng Y.O., Kadokami T. et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Nat Acad Sci USA 2000; 97: 12746-12751.
  11. Levin B., Kalman J., Mayer L. et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 4: 236-241. 323
  12. Lung B., Baron G., Butchart E.G. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-1243.
  13. Macrina F., Tritapepe L, Pompei F. et al. Procalcitonin is useful whereas C-reactive protein is not, to predict complications following coronary artery bypass surgery.Perfusion 2005; 20: 3: 169-175.
  14. Swedberg K., Cleland J., Dargie H. et al. Guidelines for the diagnosis and treatment of Chronic Heart Failure: full text (update 2005). Eur Heart J 2005; 26: 11: 1115-1140.
  15. Vahanian A., Alfieri O., Andreotti F. et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 2: 230-268.
  16. ACC/ACH 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Developed in Collaboration With the Society of Cardiovascular Anestheologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006; 48: 3: 598-675.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.